|
業務類別
|
Specialty Chemicals |
|
業務概覽
|
Balchem Corp is engaged in the development, manufacture, and marketing of specialty performance ingredients and products for various industries. The company's reportable segments are; Human Nutrition and Health, which generates maximum revenue, and provides human-grade choline nutrients and mineral amino acid chelated products through this segment for nutrition and health applications; Animal Nutrition and Health, which provides nutritional products derived from its microencapsulation and chelation technologies in addition to the essential nutrient choline chloride; and the Specialty Products segment includes re-packaging and distributing several performance gases and chemicals. Geographically, the company derives its key revenue from the United States and the rest from foreign countries. |
| 公司地址
| 5 Paragon Drive, Montvale, NJ, USA, 07645 |
| 電話號碼
| +1 845 326-5600 |
| 傳真號碼
| +1 845 326-5717 |
| 公司網頁
| https://www.balchem.com |
| 員工數量
| 1352 |
| Ms. Hatsuki Miyata |
Executive Vice President, Chief Legal Officer and Secretary |
美元 471.14K |
20/02/2026 |
| Mr. Theodore L. Harris |
Chairman of the Board, President and Chief Executive Officer |
美元 1.16M |
20/02/2026 |
| Ms. Erin L. Gilson |
Senior Director, Accounting and Financial Reporting |
-- |
19/02/2026 |
| Mr. William A. Backus |
Vice President and Chief Accounting Officer |
-- |
20/02/2026 |
| Mr. George Graham |
Senior Vice President and Chief Research and Development Officer |
-- |
20/02/2026 |
| Mr. Michael Bent Tignor |
Senior Vice President and Chief Human Resources Officer |
-- |
20/02/2026 |
| Mr. Frederic Boned |
Senior Vice President and General Manager, Human Nutrition and Health |
美元 518.13K |
20/02/2026 |
| Mr. C. Martin Bengtsson |
Executive Vice President and Chief Financial Officer |
美元 572.15K |
20/02/2026 |
| Mr. Job van L. Gunsteren |
Senior Vice President and General Manager, Specialty Products |
-- |
20/02/2026 |
| Mr. Martin Luther Reid |
Senior Vice President and Chief Supply Chain Officer |
美元 468.08K |
20/02/2026 |
|
|
| Mr. Theodore L. Harris |
Chairman of the Board, President and Chief Executive Officer |
20/02/2026 |
| Mr. David B. Fischer |
Independent Director |
20/02/2026 |
| Ms. Kathleen B. Fish |
Independent Director |
20/02/2026 |
| Mr. Matthew D. Wineinger |
Lead Independent Director |
20/02/2026 |
| Ms. Monica Vicente |
Independent Director |
20/02/2026 |
| Mr. Olivier Rigaud |
Independent Director |
20/02/2026 |
| Mr. Daniel E. Knutson |
Independent Director |
20/02/2026 |
|
|
|
|
